Plaque Psoriasis

Valerie Callender, MD, draws on her experiences in clinical practice to discuss cosmetic dermatology care practices and the challenges of this past year.

The study underscores the importance of interpreting patient-reported disease severity scores in the context of mental health factors.

Two studies demonstrated that the IL-17A and IL-17F inhibitor can lead to superior levels of skin of clearance in adult patients compared with ustekinumab or placebo. .

Todd Schlesinger, MD, talks new therapies on the horizon and those that have already proven efficacious.

The FDA approvals of biologics for atopic dermatitis and psoriasis have ushered in a new era for the once-stagnant field of pediatric dermatology.

There is a gap between the efficacy of biologics in trials and the real-world setting.

Strict avoidance of systemic corticosteroids among patients with psoriasis may be unnecessary.